Sino Biopharma keeps flat margin for $700m refi
Sino Biopharmaceutical has turned to banks for a $700m refinancing loan. It is offering the same price as it paid for the original deal, a club loan sealed in 2016.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: